Clinical Trial Details
| Trial ID: | L2039 |
| Source ID: | NCT05015894 |
| Associated Drug: | Nnc0480-0389 |
| Title: | A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: NNC0480-0389 |
| Outcome Measures: | Primary: AUC0-∞,NNC0480-0389,SD, area under the NNC0480-0389 plasma concentration time curve after a single dose, h\*nmol/L, From baseline (visit 2, day 1, pre-dose) until completion of the end-of-study visit (visit 11, day 36) | Secondary: Cmax,NNC0480-0389,SD, Maximum observed NNC0480-0389 plasma concentration after a single dose, nmol/L, From baseline (visit 2, day 1, pre-dose) until completion of the end-of-study visit (visit 11, day 36) |
| Sponsor/Collaborators: | Sponsor: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 42 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2021-08-30 |
| Completion Date: | 2022-08-02 |
| Results First Posted: | |
| Last Update Posted: | 2023-11-13 |
| Locations: | Novo Nordisk Investigational Site, Berlin, 10117, Germany |
| URL: | https://clinicaltrials.gov/show/NCT05015894 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|